TY - JOUR
T1 - Testing distance stereoacuity with the Frisby-Davis 2 (FD2) test
AU - Holmes, Jonathan M.
AU - Fawcett, Sherry L.
N1 - Funding Information:
Supported by grant EY11751 from the National Institutes of Health and Research to Prevent Blindness Inc., New York, New York (an unrestricted grant to the Mayo Clinic College of Medicine, Department of Ophthalmology).
PY - 2005/1
Y1 - 2005/1
N2 - To develop a presentation protocol for the new Frisby-Davis 2 (FD2) distance stereoacuity test. Prospective data collection. Stereoacuity was tested monocularly and binocularly in 95 patients with a variety of strabismic and nonstrabismic conditions, using the FD2, employing a modified staircase procedure. The Preschool Randot Stereoacuity test and the near Frisby test were used to determine whether a patient was stereoblind. Under monocular conditions, 35 (37%) of 95 patients passed at least the largest disparity of the FD2 indicating a problem with monocular cues. The binocular protocol was then modified to include a monocular test phase. Using the new protocol, if a patient could achieve the same stereoacuity under monocular and binocular conditions, they were deemed to have no stereopsis. Testing 28 additional stereoblind patients using the new modified protocol revealed no false positives. The FD2 stereotest is a useful measure of distance stereoacuity, provided the presentation protocol accounts for monocular cues.
AB - To develop a presentation protocol for the new Frisby-Davis 2 (FD2) distance stereoacuity test. Prospective data collection. Stereoacuity was tested monocularly and binocularly in 95 patients with a variety of strabismic and nonstrabismic conditions, using the FD2, employing a modified staircase procedure. The Preschool Randot Stereoacuity test and the near Frisby test were used to determine whether a patient was stereoblind. Under monocular conditions, 35 (37%) of 95 patients passed at least the largest disparity of the FD2 indicating a problem with monocular cues. The binocular protocol was then modified to include a monocular test phase. Using the new protocol, if a patient could achieve the same stereoacuity under monocular and binocular conditions, they were deemed to have no stereopsis. Testing 28 additional stereoblind patients using the new modified protocol revealed no false positives. The FD2 stereotest is a useful measure of distance stereoacuity, provided the presentation protocol accounts for monocular cues.
UR - http://www.scopus.com/inward/record.url?scp=11844306015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=11844306015&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2004.07.008
DO - 10.1016/j.ajo.2004.07.008
M3 - Article
C2 - 15652852
AN - SCOPUS:11844306015
SN - 0002-9394
VL - 139
SP - 193
EP - 195
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
IS - 1
ER -